<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors describe the outcome of five patients with a cardiac <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> selected among 183 patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> (2.7 %) who were given IV tissue plasminogen activator (tPA) </plain></SENT>
<SENT sid="1" pm="."><plain>No early systemic or <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> occurred </plain></SENT>
<SENT sid="2" pm="."><plain>Two patients made a complete recovery at 3 months </plain></SENT>
<SENT sid="3" pm="."><plain>Two patients had a moderate outcome </plain></SENT>
<SENT sid="4" pm="."><plain>One patient had late recurrent <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> and died </plain></SENT>
<SENT sid="5" pm="."><plain>These data suggest that the presence of a cardiac <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> is not associated with a high risk of recurrent embolism in patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> who are given IV tPA </plain></SENT>
</text></document>